Luca Benatti, Ph.D.

Luca Benatti, Ph.D.

DirectoratIRulya Therapeutics· In proxies 2023–2025

Luca Benatti, Ph.D. sits on 1 public board.

Boards1

  • IRulya TherapeuticsDirector · 1 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. IRulya TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?